ZOVYDD Trademark

Trademark Overview


On Thursday, February 18, 2021, a trademark application was filed for ZOVYDD with the United States Patent and Trademark Office. The USPTO has given the ZOVYDD trademark a serial number of 90534048. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by CureVac AG. The ZOVYDD trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases a...

Chemicals and biological preparations being biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes; Peptide carrier molecules for association with a biological macromolecule being biological preparations for use in the pharmaceutical industry; Peptidic carrier molecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry; Peptide carrier molecule in combination with a biological macromolecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry

Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders

Scientific and technological services, namely, scientific research, analysis, and testing in the field of biological molecules, in particular for identification, testing and characterisation of biological molecules; scientific and technological services, namely, scientific pre-clinical and clinical testing of macromolecules in the field of biological molecules
zovydd

General Information


Serial Number90534048
Word MarkZOVYDD
Filing DateThursday, February 18, 2021
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7204292
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Goods and ServicesChemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment or prevention of infectious diseases, autoimmune diseases and tumours, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Vaccines; Vaccines for the prophylaxis of viral diseases
Goods and ServicesChemicals and biological preparations being biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes; Peptide carrier molecules for association with a biological macromolecule being biological preparations for use in the pharmaceutical industry; Peptidic carrier molecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry; Peptide carrier molecule in combination with a biological macromolecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry
Goods and ServicesMedical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders
Goods and ServicesScientific and technological services, namely, scientific research, analysis, and testing in the field of biological molecules, in particular for identification, testing and characterisation of biological molecules; scientific and technological services, namely, scientific pre-clinical and clinical testing of macromolecules in the field of biological molecules

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 20, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCUREVAC SE
Party Type30 - Original Registrant
Legal Entity Type94 - NOT AVAILABLE
AddressTÜBINGEN 72076
DE

Party NameCUREVAC SE
Party Type20 - Owner at Publication
Legal Entity Type94 - NOT AVAILABLE
AddressTÜBINGEN 72076
DE

Party NameCUREVAC SE
Party Type11 - New Owner Before Publication
Legal Entity Type94 - NOT AVAILABLE
AddressTÜBINGEN 72076
DE

Party NameCureVac AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTübingen D-72076
DE

Trademark Events


Event DateEvent Description
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 20, 2023ASSIGNED TO EXAMINER
Thursday, June 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 8, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 8, 2023ASSIGNED TO LIE
Wednesday, March 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 21, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 11, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, January 11, 2023INQUIRY TO SUSPENSION E-MAILED
Wednesday, January 11, 2023SUSPENSION INQUIRY WRITTEN
Wednesday, November 30, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, November 28, 2022ASSIGNED TO EXAMINER
Monday, November 21, 2022SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, April 8, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, April 8, 2022LETTER OF SUSPENSION E-MAILED
Friday, April 8, 2022SUSPENSION LETTER WRITTEN
Friday, March 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 16, 2021NON-FINAL ACTION E-MAILED
Thursday, September 16, 2021NON-FINAL ACTION WRITTEN
Monday, September 13, 2021ASSIGNED TO EXAMINER
Thursday, May 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 22, 2021NEW APPLICATION ENTERED